ArticleJAMA internal medicine2020

Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life Saving.

Colette DeJong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.